Climacteric

Is combined estrogen/progestogen hormone therapy worth the risk?
pp. 177-179(3)
Authors: Sturdee D.W.; MacLennan A.H.

Imaging the brain in healthy postmenopausal users and non-users of hormone replacement therapy
pp. 180-183(4)
Authors: Compton J.; Murphy D.

Progesterone creams: do they work?
pp. 184-187(4)
Author: Wren B.G.

Hormone replacement therapy in climacteric and aging brain
pp. 188-203(16)
Authors: Genazzani A.R.; Gambacciani M.; Simoncini T.; Schneider H.P.G.

Plasma leptin in postmenopausal women with coronary artery disease: effect of transdermal 17-estradiol and intermittent medroxyprogesterone acetate
pp. 204-210(7)
Authors: Os I.; Os A.; Abdelnoor M.; Larsen A.; Birkeland K.; Westheim A.

Effects on climacteric symptoms, bone and lipoprotein metabolism of hormone replacement therapy delivered by estradiol-releasing intravaginal rings: a pilot study
pp. 211-220(10)
Authors: Farish E.; Barnes J.F.; Rankin M.; Hart D.M.

Comparison of the proliferative effects of estradiol and conjugated equine estrogens on human breast cancer cells and impact of continuous combined progestogen addition
pp. 221-227(7)
Authors: Mueck A.O.; Seeger H.; Wallwiener D.

Acute effects of tibolone on cerebral vascular reactivity in vitro
pp. 228-237(10)
Authors: Lund C.O.; Nilas L.; Dalsgaard T.; Pedersen S.H.; Ottesen B.

Vitamin C improves endothelial function in healthy estrogen-deficient postmenopausal women
pp. 238-247(10)
Authors: McSorley P.T.; Young I.S.; Bell P.M.; Fee J.P.H.; McCance D.R.

Effect of raloxifene on sexual function in postmenopausal women
pp. 248-256(9)
Authors: Kessel B.; Nachtigall L.; Plouffe L.; Siddhanti S.; Rosen A.; Parsons A.

The new terminology
pp. 257-258(2)
Authors: Figueroa-Casas P.; Palacios S.

Worldwide Literature Reviews
pp. 259-262(4)